Video

Dr. Haugen Describes the 82nd Annual ATA Meeting

Dr. Bryan Haugen, from University of Colorado School of Medicine, Describes the 82nd Annual Meeting of the American Thyroid Association.

Bryan R. Haugen, MD, Head, Division of Endocrinology, Metabolism, and Diabetes, Department of Medicine, University of Colorado School of Medicine, describes topics and features of the 82nd Annual Meeting of the American Thyroid Association (ATA), taking place from September 19-23, 2012, in Quebec City, Canada.

The most recent ATA meeting features translational and clinical sessions highlighting recent work and breakthroughs in thyroid hormone action, the science of thyroid cancer, developmental biology, and autoimmunity. Over the course of the five-day conference, a number of lectures provide information to hrlp move the field of thyroidology forward, Haugen states.

Haugen, the President-Elect of ATA, provides further information on the development of the 2013 ATA meeting, which will be held in San Juan, Puerto Rico in October 2013.

<<<

View coverage from the 2012 ATA Annual Meeting

Related Videos
Albert Grinshpun, MD, MSc, head, Breast Oncology Service, Shaare Zedek Medical Center
Erica L. Mayer, MD, MPH, director, clinical research, Dana-Farber Cancer Institute; associate professor, medicine, Harvard Medical School
Stephanie Graff, MD, and Chandler Park, FACP
Mariya Rozenblit, MD, assistant professor, medicine (medical oncology), Yale School of Medicine
Maxwell Lloyd, MD, clinical fellow, medicine, Department of Medicine, Beth Israel Deaconess Medical Center
Neil Iyengar, MD, and Chandler Park, MD, FACP
Azka Ali, MD, medical oncologist, Cleveland Clinic Taussig Cancer Institute
Rena Callahan, MD, and Chandler Park, MD, FACP
Hope S. Rugo, MD, FASCO, Winterhof Family Endowed Professor in Breast Cancer, professor, Department of Medicine (Hematology/Oncology), director, Breast Oncology and Clinical Trials Education; medical director, Cancer Infusion Services; the University of California San Francisco Helen Diller Family Comprehensive Cancer Center
Virginia Kaklamani, MD, DSc, professor, medicine, Division of Hematology-Medical Oncology, The University of Texas (UT) Health Science Center San Antonio; leader, breast cancer program, Mays Cancer Center, UT Health San Antonio MD Anderson Cancer Center